Table 3.
Anti-HBs titer (mIU/ml) | Group 1 (N = 25) Hexavac® n (%) | Group 2 (N = 5) Infanrix Hexa® n (%) | p-value |
< 10 | 2 (8.0) | 0 | 1.0000* |
10–99 | 4 (16.0) | 2 (40.0) | 0.2854** |
≥ 100 | 19 (76.0) | 3 (60.0) | - |
* < 10 vs ≥ 10; ** 10–99 vs ≥ 100
Anti-HBs titer (mIU/ml) | Group 1 (N = 25) Hexavac® n (%) | Group 2 (N = 5) Infanrix Hexa® n (%) | p-value |
< 10 | 2 (8.0) | 0 | 1.0000* |
10–99 | 4 (16.0) | 2 (40.0) | 0.2854** |
≥ 100 | 19 (76.0) | 3 (60.0) | - |
* < 10 vs ≥ 10; ** 10–99 vs ≥ 100